The Board of Directors of PharmaCyte Biotech, Inc has authorized a buyback plan on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | -3.02% | -2.79% | -3.24% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.24% | 17.67M | |
+29.98% | 682B | |
+32.39% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.50% | 240B | |
+9.56% | 209B | |
-9.04% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- PharmaCyte Biotech, Inc authorizes a Buyback Plan.